JAMA Network
About The Study: The results of this study indicated that clinical outcomes were similar among patients with opioid use disorder who were treated by clinicians with high and low telemedicine use during the COVID-19 pandemic, suggesting that telemedicine is a comparable alternative to in-person opioid use disorder care. There was no evidence that telemedicine was associated with increased access to or improved quality of opioid use disorder treatment.
Authors: Michael L. Barnett, M.D., M.S., of the Harvard T.H. Chan School of Public Health in Boston, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2022.52381)
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
